Bioidentical Hormones are Safer, More Effective than Synthetic Hormones
Posted Oct 25 2010 12:38pm
In a new analysis of the women involved in the Women’s Health Initiative (WHI), researchers discovered that synthetic hormone replacement therapy used after menopause not only increased the risk of breast cancer in women, but also increased their risk of dying from the disease, when compared with women who did not receive treatment. These new findings were recently published in the October 20th issue of the Journal of the American Medical Association.
“There is actually a large body of evidence, based on well documented studies, that supports the efficacy and safety of bioidentical hormones.”
The WHI was a federally funded study that analyzed more than 16,500 postmenopausal women who were given either hormone replacement therapy or a placebo. The study was discontinued three years early in 2002, after researchers discovered that the hormones being used were actually increasing the risk of breast cancer, stroke, heart disease and pulmonary embolism. In the years following the WHI trials, researchers went on to conduct a series of follow-up studies, many of which attested to the dangers of using synthetic forms of hormone replacement therapy.
After the WHI came to a screeching halt, the number of women using hormone therapy drugs plummeted precipitously. Today, millions of women still opt for treatment; however, many have turned to natural alternatives, such as bioidentical hormone replacement therapy (BHRT). Not only are bioidentical hormones more effective at treating symptoms of menopause, but so far there is no evidence that says bioidentical hormones increase the likelihood of breast cancer. In fact, several studies have shown that women who use BHRT can actually reduce the risk of breast cancer and heart disease. French researchers conducted a study involving 54,000 postmenopausal women and found that women who used BHRT reduced their breast cancer risk by 10 percent.